Enanta Pharmaceuticals | 営業利益

Operating Profit 変化する 日付
AbbVie USD 3.2B 914M 2023-12
Amgen USD 1.27B 819M 2023-12
Arrowhead Research USD -136545000 28.22M 2023-12
AstraZeneca USD 1.95B 502M 2023-09
Bristol-Myers Squibb USD 1.85B 473M 2023-12
Gilead Sciences USD 1.61B 1.01B 2023-12
GlaxoSmithKline GBP 1.95B 192M 2023-09
Halozyme Therapeutics USD 101.04M 12.76M 2023-12
Incyte USD 187.27M 27.44M 2023-12
Insmed USD -178272000 30.6M 2023-12
Ionis Pharmaceuticals USD 20.68M 166.04M 2023-12
Ligand Pharmaceuticals USD -3458000 6.54M 2023-12
Merck USD -1933000000 7.68B 2023-12
Neurocrine Biosciences USD 141.2M 67.6M 2023-09
Pfizer USD -6551000000 3.61B 2023-12
PTC Therapeutics USD -131738000 13.57M 2023-12
Roche Holding CHF 9.76B 3.84B 2023-06
Sarepta Therapeutics USD -48342000 16.82M 2023-09
Vertex Pharmaceuticals USD 1.04B 11.7M 2023-09



Enanta Pharmaceuticals 営業利益 - 現在の値は、過去のデータ、予測、統計、チャートや経済カレンダー - Apr 2024.